Interventions for the initial, active phase of thyroid eye disease (TED) include treatments for dry eye and immunosuppression. Once the disease stabilizes, usually after 18-36 months, surgical procedures can help restore eye function and appearance.Read More
As optical coherence tomography quickly evolves to more specific modalities with higher resolution and enhanced depth, its importance in clinical practice will grow, particularly with more portable units.
An 85-year-old woman presents with chronic corneal edema and presumed partial limbal cell deficiency with superficial and deep stromal neovascularization and opacity. How would you treat her?
When old vision correction technology meets the latest in refractive surgery, challenges ensue. Achieving patient and surgical goals requires an innovative approach.
When a 40-year-old woman with a prior episode of herpes simplex keratitis wanted vision correction, the Visian Implantable Collamer Lens offered a safe option.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
MIGS for treating glaucoma is designed for combined use with cataract surgery. A breakthrough product, the iStent has set a new standard in eye care.
Once the exclusive domain of glaucoma surgeons, angle-closure glaucoma can now be treated with cataract surgery. Find out how it worked in two specific cases.
Discover how this novel minimally invasive technique may avoid the potential morbidity associated with a large corneoscleral incision, allowing for rapid visual recovery.
Discover how Cleveland Clinic physicians are hoping to improve survival in uveal melanoma by identifying patients with micrometastases—and suppressing them before they progress to macrometastases.
A new technique developed by Cole Eye Institute’s Elias Traboulsi, MD, has been shown to improve surgical outcomes for the roughly 5 percent of patients with thyroid eye disease who require strabismus surgery.
The use of optical coherence tomography (OCT) is expanding into previously uncharted territory: the choroid. As researchers fine-tune enhanced depth imaging OCT, ophthalmologists are gaining a new tool to evaluate choroidal conditions, retinal degeneration and ocular tumors.